Free Trial

Coherus Oncology (CHRS) News Today

Coherus Oncology logo
$0.73 -0.01 (-1.59%)
As of 06/30/2025 04:00 PM Eastern

CHRS Latest News

CHRS Coherus Oncology, Inc.
Coherus Oncology Inc.
Coherus BioSciences, Inc. (CHRS): A Bull Case Theory
Coherus reports promising cancer treatment results
Coherus Biosciences price target lowered to $1.05 from $1.50 at UBS
Coherus Biosciences completes divestiture of UDENYCA franchise
Coherus Biosciences announces repurchase of $170M of convertible notes
A Closer Look At Coherus BioSciences' Earnings
Coherus BioSciences, Inc. (CHRS): A Bull Case Theory
Q4 2024 Coherus BioSciences Inc Earnings Call
Get Coherus Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHRS and its competitors with MarketBeat's FREE daily newsletter.

CHRS Media Mentions By Week

CHRS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CHRS
News Sentiment

1.89

0.90

Average
Medical
News Sentiment

CHRS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CHRS Articles
This Week

1

2

CHRS Articles
Average Week

Get Coherus Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHRS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CHRS) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners